Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 1/20 | 0.50 |
| ▸ | CCR6 | P51684 | 1/20 | 0.45 |
| ▸ | KIF11 | P52732 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | CTSS | P25774 | 1/20 | 0.40 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30841758 | 1.00 | DGAT1 (0.50) | DGAT1CCR6KIF11KMT2AMAOB | |
| SCHEMBL6065413 | 0.94 | DGAT1 (0.47) | DGAT1CCR6KIF11KMT2AMAOB | |
| SCHEMBL6065411 | 0.94 | DGAT1 (0.47) | DGAT1CCR6KIF11KMT2AMAOB | |
| SCHEMBL6256028 | 0.85 | DGAT1 (0.63) | DGAT1CCR6KIF11CTSSTRPA1 | |
| SCHEMBL1584633 | 0.84 | DGAT1 (0.42) | DGAT1CCR6KIF11SCN10ATRPA1 | |
| SCHEMBL14676801 | 0.84 | DGAT1 (0.42) | DGAT1CCR6KIF11CTSSSCN10A | |
| SCHEMBL11535669 | 0.83 | ALDH1A1 (0.44) | DGAT1CCR6KIF11CTSSALDH1A1 | |
| SCHEMBL21045811 | 0.82 | DGAT1 (0.44) | DGAT1KIF11CTSSNPSR1TRPA1 | |
| SCHEMBL11537287 | 0.82 | CTSS (0.48) | DGAT1CCR6CTSSSCN10AALDH1A1 | |
| SCHEMBL14973267 | 0.79 | KMT2A (0.43) | DGAT1KIF11KMT2AALDH1A1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117199519-A | Electrolyte, preparation method and application thereof, and lithium battery | 北京纳米能源与系统研究所 | 2023-12-08 | — | — | CN | claimed |
| EP-4676591-A2 | SMALL MOLECULE FSH RECEPTOR MODULATORS | Ferring B.V. (NL) | 2026-01-14 | — | — | EP | disclosed |
| US-20260001870-A1 | INHIBITOR COMPOUNDS | Cincera Therapeutics Pty Ltd (AU) | 2026-01-01 | — | — | US | disclosed |
| EP-4634169-A1 | 3-FLUORO-4-HYDROXYBENZMIDE-CONTAINING INHIBITORS AND/OR DEGRADERS AND USES THEREOF | Pfizer Inc. (US) | 2025-10-22 | — | — | EP | disclosed |
| US-12448371-B2 | Inhibitor compounds | Cincera Therapeutics Pty Ltd (AU) | 2025-10-21 | — | — | US | disclosed |
| EP-4598908-A1 | HSD17B13 INHIBITORS AND/OR DEGRADERS | Pfizer Inc. (US) | 2025-08-13 | — | — | EP | disclosed |
| WO-2025061707-A1 | SYNTHESIS OF SULFOXIMINES CONTAINING A BENZIMIDAZOLE MOIETY | SYNGENTA CROP PROTECTION AG (CH) | 2025-03-27 | — | — | WO | disclosed |
| WO-2024184461-A2 | SMALL MOLECULE FSH RECEPTOR MODULATORS | FERRING B.V. (NL) | 2024-09-12 | — | — | WO | disclosed |
| CN-114450281-B | Inhibitor compounds | 辛塞拉治疗私人有限公司 | 2024-08-16 | — | — | CN | disclosed |
| US-20240238425-A1 | HSD17B13 Inhibitors and/or Degraders | PFIZER INC. (US) | 2024-07-18 | — | — | US | disclosed |
| US-5436267-A | An O-(N-2-carbamylphenyl)-heterocyclic oxime; insecticides; fungicides; miticides; nematocides; plant growth regulators; herbicides; viricides; attractants | ISHIHARA SANGYO KAISHA, LTD. (JP) | 1995-07-25 | — | — | US | disclosed |
| EP-0498396-A2 | N-phenylcarbamate compound, process for preparing the same and biocidal composition for control of harmful organisms | ISHIHARA SANGYO KAISHA, Ltd. (JP) | 1992-08-12 | — | — | EP | disclosed |
| US-5032607-A | Enzyme inhibitors | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-07-16 | — | — | US | disclosed |
| US-4999364-A | Azole derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-03-12 | — | — | US | disclosed |
| EP-0354683-A1 | Azole derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1990-02-14 | — | — | EP | disclosed |
| US-4866086-A | PHENYLTRIAZOLYL OLEFINIC AROMATASE INHIBITORS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1989-09-12 | — | — | US | disclosed |
| EP-0299683-A2 | Heterocyclic olefinic compounds and their use as aromatase inhibitors | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1989-01-18 | — | — | EP | disclosed |
| EP-0034917-B1 | 2-SUBSTITUTED-5-TRIFLUOROMETHYLPYRIDINES AND A PROCESS FOR PRODUCING THE SAME | ISHIHARA SANGYO KAISHA LTD. (JP) | 1984-08-08 | — | — | EP | disclosed |
| US-4367336-A | 2-Substituted-5-trifluoromethylpyridines and process for producing the same | ISHIHARA SANGYO KAISHA, LTD. (JP) | 1983-01-04 | — | — | US | disclosed |
| EP-0034917-A1 | 2-Substituted-5-trifluoromethylpyridines and a process for producing the same | ISHIHARA SANGYO KAISHA LTD. (JP) | 1981-09-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240238425-A1 | HSD17B13 Inhibitors and/or Degraders | HSD17B13, HSD17B3, HSD17B1 | DGAT1 677/4885CCR6 4283/4885KIF11 3816/4885 |
| US-20260001870-A1 | INHIBITOR COMPOUNDS | CES1, NCEH1, NR1H2 | DGAT1 41/4885CCR6 946/4885KIF11 3494/4885 |
| US-12448371-B2 | Inhibitor compounds | SERPINB1, MMP1, SSB | DGAT1 164/4885CCR6 4390/4885KIF11 4192/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.